RCUS

Arcus Biosciences Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 3/10
  • Value↓ 0/10
Arcus Biosciences sales and earnings growth
RCUS Growth
Neutral
  • Revenue Y/Y↓ -4.26%
  • EPS Y/Y↓ -4.78%
  • FCF Y/Y↓ -175.00%
Arcus Biosciences gross and profit margin trends
RCUS Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -142.90%
  • ROIC 5Y↓ -35.18%
Arcus Biosciences net debt vs free cash flow
RCUS Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -43.1

Arcus Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗